TR201204532T1 - Treatment using re-programmed mature adult cells. - Google Patents
Treatment using re-programmed mature adult cells.Info
- Publication number
- TR201204532T1 TR201204532T1 TR2012/04532T TR201204532T TR201204532T1 TR 201204532 T1 TR201204532 T1 TR 201204532T1 TR 2012/04532 T TR2012/04532 T TR 2012/04532T TR 201204532 T TR201204532 T TR 201204532T TR 201204532 T1 TR201204532 T1 TR 201204532T1
- Authority
- TR
- Turkey
- Prior art keywords
- cells
- differentiated
- patient
- retro
- trans
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Retro (geriye dönük olarak)-farklılaştırılmış, trans (dokular arası olarak)-farklılaştırılmış veya yeniden farklılaştırılmış hücreler gibi yeniden programlanmış hücreler kullanılarak bır hastadaki çeşitli hastalık, bozukluk veya durumların tedavi edilmesine ilişkin bir yöntem. Yöntem, hastadan adanmış hücrelerin elde edilmesini, adanmış hücreler retro-farklılaştırmaya tabi tutularak retro-farklılaştırılmış hedef hücrelerin elde edilmesini ve retro-farklılaştırılmış hücrelerin hastaya verilmesini içermektedir. Belirli uygulamalarda yöntem, hastadan adanmış hücrelerin elde edilmesini, adanmış hücreler trans-farklılaştırmaya tabi tutularak trans-farklılaştırılmış hedef hücrelerin elde edilmesini ve trans-farklılaştırılmış hedef hücrelerin hastaya verilmesini içermektedir. Retro-farklılaştırılmış veya trans-farklılaştırılmış hedef hücreler hastadaki doku veya hücreleri onarmakta veya yenilemektedir.A method of treating a variety of diseases, disorders, or conditions in a patient using reprogrammed cells, such as retro (retrospectively) -differentiated, trans-tissue-differentiated, or differentiated cells. The method comprises obtaining dedicated cells from the patient, subjecting the dedicated cells to retro-differentiation to obtain retro-differentiated target cells and delivering the retro-differentiated cells to the patient. In certain embodiments, the method comprises obtaining dedicated cells from the patient, subjecting the dedicated cells to trans-differentiation to obtain trans-differentiated target cells, and delivering the trans-differentiated target cells to the patient. Retro-differentiated or trans-differentiated target cells repair or regenerate tissues or cells in the patient.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201204532 | 2009-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201204532T1 true TR201204532T1 (en) | 2012-09-21 |
Family
ID=47005062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2012/04532T TR201204532T1 (en) | 2009-10-19 | 2009-10-19 | Treatment using re-programmed mature adult cells. |
Country Status (1)
Country | Link |
---|---|
TR (1) | TR201204532T1 (en) |
-
2009
- 2009-10-19 TR TR2012/04532T patent/TR201204532T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2012000157A1 (en) | Treatment using reprogrammed mature adult cells | |
TR201911199T4 (en) | Treatment to increase cell growth. | |
MX2022004300A (en) | Composition and method for diagnosis and treatment of diseases associated with neurite degeneration. | |
WO2009111375A3 (en) | Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas | |
MY176820A (en) | Egfr and c-met fibronectin type iii domain binding molecules | |
IN2015DN02938A (en) | ||
MX342200B (en) | Method for processing mesenchymal stem cells and the use thereof in the treatment of diseases associated with oxidative stress. | |
MX2019006379A (en) | Small molecule trail gene induction by normal and tumor cells as an anticancer therapy. | |
WO2009089110A3 (en) | Methods for repair and regeneration of bone marrow | |
EA201101568A1 (en) | TREATMENT OF EX VIVO IMMUNOLOGICAL DISORDERS THROUGH PKC-TETA INHIBITORS | |
MX2020011415A (en) | Methods of using zscan4 for rejuvenating human cells. | |
BR112013004700A2 (en) | method for preventing or treating cardiovascular disease or disorder | |
MX362098B (en) | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells. | |
WO2010097788A3 (en) | Visfatin therapeutic agents for the treatment of acne and other conditions | |
NZ616048A (en) | Administration of iloprost as aerosol bolus | |
EP2400971A4 (en) | Treatment of immunosuppression-related disorders | |
MX2013015347A (en) | Egfr targeted therapy. | |
MX354667B (en) | Methods for treating a stroke-related sensorimotor impairment using aminopyridines. | |
MX2012002456A (en) | Novel forms of a multicyclic compound. | |
TR201204532T1 (en) | Treatment using re-programmed mature adult cells. | |
WO2012068341A3 (en) | Wnt1 for treatment of cardiovascular disorders and injuries | |
CL2015003505A1 (en) | Mesenchymal stem cells derived from chorion and conditioned medium as an inducer of angiogenesis application in the treatment of cardiac degeneration | |
WO2014005153A3 (en) | Methods for treating mds1-evi1 mediated cancer | |
ATE542547T1 (en) | USE OF ADIATIVE TISSUE CELL FRACTIONS FOR TISSUE REGENERATION AFTER RADIATION | |
WO2012177565A3 (en) | Regulation of macrophage activation using mir - 125b |